DNA X, Inc. — Form 10-Q
Filed August 19, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
This is a standard quarterly report filing for the period ending June 30, 2026, submitted on August 19, 2026. The filing consists of standard SEC forms (10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2) and XBRL data files. No specific financial results, material transactions, counterparties, dollar amounts, share counts, guidance changes, or business developments are provided in the filing metadata itself—only structural and administrative information about the filing.
Why this rating
Routine quarterly disclosure filing; no material transactions, guidance changes, or business events described in the available text.
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.